Abstract
Innate immune receptors often induce activation of conventional dendritic cells (cDCs) and enhance antigen (cross-)presentation, favouring immune responses. DNGR-1 (CLEC9A), a receptor expressed by type 1 cDCs (cDC1s) and implicated in immune responses to viruses and cancer, recognises F-actin exposed on dead cell remnants and promotes cross-presentation of associated antigens. Here, we show that recruitment of phosphatase SHIP1, a process governed by a single amino acid residue adjacent to the signalling motif of the receptor, partly explains how DNGR-1 fails to trigger cDC1 activation in vitro. Substituting this residue converts DNGR-1 into an activating receptor but decreases induction of cross-presentation of dead cell-associated antigens. Introducing the reverse mutation into the related receptor Dectin-1 impairs its activation capacity while enhancing its ability to promote cross-presentation. These findings reveal a functional trade-off in receptor signalling and suggest that DNGR-1 has evolved to prioritise antigen cross-presentation over cellular activation, possibly to minimise inflammatory responses to dead cells.
| Original language | English |
|---|---|
| Pages (from-to) | 6857-6891 |
| Number of pages | 35 |
| Journal | EMBO Journal |
| Volume | 44 |
| Issue number | 23 |
| DOIs | |
| Publication status | Published - Dec 2025 |
Keywords
- Activation
- CLEC9A
- Cross-presentation
- DNGR-1
- cDC1
- Signal Transduction
- Humans
- Receptors, Mitogen
- Receptors, Immunologic/metabolism
- Cross-Priming/immunology
- Animals
- Antigen Presentation
- Lectins, C-Type/genetics
- Dendritic Cells/immunology
- Mice
Fingerprint
Dive into the research topics of 'DNGR-1 signalling limits dendritic cell activation for optimal antigen cross-presentation'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver